Healthcare provider profile · identity verified

Kyaw Tun, M.D.

Internal Medicine · BAKERSFIELD, CA · NPI 1841268455

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	609	200
Atorvastatin Calcium	Atorvastatin Calcium	487	176
Losartan Potassium	Losartan Potassium	359	126
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	314	84
Levothyroxine Sodium	Levothyroxine Sodium	227	74
Metformin Hcl Er	Metformin Hcl	206	79
Pantoprazole Sodium	Pantoprazole Sodium	205	81
Amlodipine Besylate	Amlodipine Besylate	198	70
Lisinopril	Lisinopril	198	71
Gabapentin	Gabapentin	146	49
Albuterol Sulfate Hfa	Albuterol Sulfate	137	81
Metoprolol Tartrate	Metoprolol Tartrate	133	52
Potassium Chloride	Potassium Chloride	132	56
Wixela Inhub	Fluticasone Propion/Salmeterol	129	48
Tamsulosin Hcl	Tamsulosin Hcl	120	49
Ozempic	Semaglutide	118	29
Finasteride	Finasteride	114	36
Terazosin Hcl	Terazosin Hcl	110	42
Glipizide	Glipizide	104	41
Metformin Hcl	Metformin Hcl	104	38
Prednisone	Prednisone	104	84
Metoprolol Succinate	Metoprolol Succinate	101	36
Allopurinol	Allopurinol	100	35
Spiriva Respimat	Tiotropium Bromide	89	31
Alendronate Sodium	Alendronate Sodium	83	38
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	83	13
Jardiance	Empagliflozin	82	34
Atenolol	Atenolol	79	28
Carvedilol	Carvedilol	73	34
Omeprazole	Omeprazole	72	33
Tramadol Hcl	Tramadol Hcl	72	23
Ipratropium Bromide	Ipratropium Bromide	71	35
Hydralazine Hcl	Hydralazine Hcl	69	26
Pradaxa	Dabigatran Etexilate Mesylate	69	26
Bisoprolol Fumarate	Bisoprolol Fumarate	64	19
Clopidogrel	Clopidogrel Bisulfate	64	25
Pregabalin	Pregabalin	61	24
Furosemide	Furosemide	60	29
Valsartan	Valsartan	57	25
Cephalexin	Cephalexin	55	47
Trazodone Hcl	Trazodone Hcl	54	24
Lorazepam	Lorazepam	47	13
Humulin N	Insulin Nph Human Isophane	46	16
Doxycycline Monohydrate	Doxycycline Monohydrate	45	40
Mirtazapine	Mirtazapine	45	18
Ezetimibe	Ezetimibe	44	20
Meloxicam	Meloxicam	44	23
Nifedipine Er	Nifedipine	44	15
Sumatriptan Succinate	Sumatriptan Succinate	44	suppressed
Azelastine Hcl	Azelastine Hcl	43	14
Montelukast Sodium	Montelukast Sodium	43	15
Duloxetine Hcl	Duloxetine Hcl	41	15
Ropinirole Hcl	Ropinirole Hcl	41	17
Hydrochlorothiazide	Hydrochlorothiazide	40	19
Eliquis	Apixaban	37	suppressed
Buspirone Hcl	Buspirone Hcl	36	13
Glipizide-Metformin	Glipizide/Metformin Hcl	36	13
Ciprofloxacin Hcl	Ciprofloxacin Hcl	34	32
Clonidine	Clonidine	33	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	33	15
Chlorthalidone	Chlorthalidone	32	11
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	32	14
Triamcinolone Acetonide	Triamcinolone Acetonide	30	13
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	30	15
Fenofibrate	Fenofibrate	28	suppressed
Terbinafine Hcl	Terbinafine Hcl	28	17
Breyna	Budesonide/Formoterol Fumarate	27	23
Famotidine	Famotidine	27	16
Fluoxetine Hcl	Fluoxetine Hcl	27	suppressed
Ibuprofen	Ibuprofen	26	13
Fluconazole	Fluconazole	25	14
Primidone	Primidone	25	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	24	24
Lactulose	Lactulose	24	suppressed
Mupirocin	Mupirocin	24	15
Estradiol	Estradiol	23	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	23	13
Sertraline Hcl	Sertraline Hcl	23	suppressed
Propranolol Hcl	Propranolol Hcl	22	suppressed
Fluocinonide	Fluocinonide	21	12
Alprazolam	Alprazolam	20	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	20	18
Bupropion Xl	Bupropion Hcl	20	11
Hydrocortisone	Hydrocortisone	20	12
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	20	suppressed
Azithromycin	Azithromycin	19	19
Temazepam	Temazepam	19	suppressed
Humulin N Kwikpen	Insulin Nph Human Isophane	18	suppressed
Ofloxacin	Ofloxacin	18	14
Ondansetron Hcl	Ondansetron Hcl	18	suppressed
Amoxicillin	Amoxicillin	17	14
Cefuroxime	Cefuroxime Axetil	17	16
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Ondansetron Odt	Ondansetron	17	11
Valacyclovir	Valacyclovir Hcl	17	suppressed
Acyclovir	Acyclovir	16	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	16	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	16	suppressed
Midodrine Hcl	Midodrine Hcl	16	suppressed
Nitroglycerin	Nitroglycerin	16	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Citalopram Hbr	Citalopram Hydrobromide	15	suppressed
Donepezil Hcl	Donepezil Hcl	15	suppressed
Metronidazole	Metronidazole	15	14
Clonazepam	Clonazepam	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Gavilyte-C	Peg3350/Sod Sulf,bicarb,cl/Kcl	14	14
Tizanidine Hcl	Tizanidine Hcl	14	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Baclofen	Baclofen	13	suppressed
Cilostazol	Cilostazol	13	suppressed
Colchicine	Colchicine	13	suppressed
Erythromycin	Erythromycin Base	13	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	13	suppressed
Lubiprostone	Lubiprostone	13	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	13	suppressed
Veo Insulin Syringe	Syrge-Ndl,ins 0.3 Ml Half Mark	13	suppressed
Fluorouracil	Fluorouracil	12	suppressed
Humalog	Insulin Lispro	12	suppressed
Veo Insulin Syringe	Syringe And Needle,insulin,1ml	12	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Levofloxacin	Levofloxacin	11	suppressed
Tadalafil	Tadalafil	11	suppressed
Topiramate	Topiramate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error